BOTHELL, Wash., Sept. 20 /PRNewswire-FirstCall/ -- Nastech Pharmaceutical Company Inc. announced today that it will present at the UBS Global Life Sciences Conference on Wednesday, September 26, 2007 at 12:00 p.m. Eastern Time at the Grand Hyatt in New York City.
To access the live audio webcast for this conference, please log on to Nastech’s website at http://www.nastech.com approximately 15 minutes prior to the presentation in order to register and download any necessary software. A replay of the audio presentation will be available following the event.
About Nastech
Nastech is a biopharmaceutical company developing innovative products based on proprietary molecular biology-based drug delivery technologies. Nastech and our collaboration partners are developing products for multiple therapeutic areas including osteoporosis, obesity, diabetes, autism, respiratory diseases and inflammatory conditions. Additional information about Nastech is available at http://www.nastech.com.
CONTACTS: Nastech Ed Bell Director, Investor Relations (425) 908-3639 ir@nastech.com Russo Partners / LLC Matthew Haines (Investors/Media) (212) 845-4235
Nastech Pharmaceutical Company Inc.
CONTACT: Ed Bell, Director, Investor Relations of Nastech PharmaceuticalCompany Inc., +1-425-908-3639, ir@nastech.com, or Matthew Haines of RussoPartners|LLC, +1-212-845-4235, for Nastech Pharmaceutical Company Inc.
Web site: http://www.nastech.com/
